Lipoatrophy Associated With Glatiramer Acetate Injections for the Treatment of Multiple Sclerosis

We present a 35-year-old woman with symmetrical lipoatrophy induced by daily glatiramer acetate injections. Glatiramer is indicated as an effective treatment for relapsing-remitting multiple sclerosis (MS). This adverse effect has not been widely reported in the literature; to our knowledge, this is only the seventh reported case of this phenomenon. We suspect that more cases will be identified in the future as glatiramer injections become increasingly prescribed for patients with MS.